Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.77 USD | 0.00% | -1.58% | -31.54% |
May. 13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
May. 10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.54% | 367M | |
+42.59% | 54.04B | |
+43.57% | 41.96B | |
-1.32% | 41.92B | |
-7.59% | 28.35B | |
+11.72% | 26.35B | |
-22.02% | 19B | |
+7.71% | 13B | |
+28.43% | 12.28B | |
+25.69% | 12.19B |
- Stock Market
- Equities
- ORGO Stock
- News Organogenesis Holdings Inc.
- Organogenesis : Credit Suisse Adjusts Organogenesis Holdings' Price Target to $9 from $8, Keeps Outperform Rating